HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol → HCID 86693205, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol | HCID 58221468 | — |
| Reactant | HCID 86693206 | HCID 86693206 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Product | HCID 86693205 | HCID 86693205 | 21% |
Reaction Steps
Similar to as described in General Procedure G with the exception of replacing PdCl2(PPh3)2 with Pd (PPh3)4, 2-chloro-6,7-dihydroimidazo[1,2-d]pyrido[3,2-b][1,4]oxazepine-9-carboxamide was reacted with (R)-2-(5-methylisoxazol-3-yl)but-3-yn-2-ol (US2012/214762A1) to give the titled compound as a white solid (36 mg, 21%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09034866B2 |
| Source dataset | uspto-grants-2015_05 |
| ORD ID | ord-b47192fd376a47b0852dbcc63ab3e830 |
| Source note | uspto-grants-2015_05 |